Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation

NCT00149877 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00149877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00149877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
February 28, 2006
Enrollment
250
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation